Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram Negative Organism”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableUnknownNCT03980197
What this trial is testing

Strategy to Prevent Transmission of Multidrug-resistant Gram-negative Organisms in ICU

Who this might be right for
Antibiotic Resistant Infection
Sung-Han Kim 2,500
Early research (Phase 1)Ended earlyNCT02922816
What this trial is testing

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Who this might be right for
Infection Due to Resistant Organism
Emory University 11
Not applicableStudy completedNCT04574596
What this trial is testing

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Who this might be right for
E Coli Infection
Duke University 300
Not applicableStudy completedNCT00443885
What this trial is testing

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

Who this might be right for
Gram Negative Organism
University of Pittsburgh 500
Not applicableStudy completedNCT04715464
What this trial is testing

Active Surveillance Cultures for Multidrug Resistant Gram-Negative Organisms at an Acute Care Hospital

Who this might be right for
Infection
Methodist Health System 2,878
Testing effectiveness (Phase 2)Looking for participantsNCT05835206
What this trial is testing

Further MT for Antibiotic-Resistant Bacterial Colonization

Who this might be right for
Intestinal Multi-drug Resistant Organism Colonization
Emory University 40
Not applicableNot Yet RecruitingNCT07671014
What this trial is testing

Metagenomic Analysis of the Pharynx in High Risk Partners

Who this might be right for
GonorrheaNeisseria GonorrheaNeisseria Meningitidis+1 more
Guy's and St Thomas' NHS Foundation Trust 100
Large-scale testing (Phase 3)Looking for participantsNCT04188743
What this trial is testing

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

Who this might be right for
Resistance Bacterial
University Hospital, Ghent 150
Testing effectiveness (Phase 2)Study completedNCT05632315
What this trial is testing

PMT for MDRO Decolonization

Who this might be right for
Multidrug Resistant Bacterial InfectionEnterobacteriaceae InfectionsPseudomonas Aeruginosa+2 more
University of Pennsylvania 32
Large-scale testing (Phase 3)Study completedNCT00079989
What this trial is testing

Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms

Who this might be right for
Gram-Negative Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer 115
Not applicableUnknownNCT04055922
What this trial is testing

Comparison of Solid Organ Transplant

Who this might be right for
Gram-Negative Bacterial InfectionsGram-negative BacteremiaMultidrug-Resistant Organism+2 more
Methodist Health System 150
Not applicableStudy completedNCT06131749
What this trial is testing

Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa

Who this might be right for
Sexually Transmitted Infections (Not HIV or Hepatitis)Premature BirthPregnancy; Infection+10 more
University of Bern 603
Testing effectiveness (Phase 2)WithdrawnNCT06214403
What this trial is testing

Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation

Who this might be right for
Gram-negative BacteremiaMicrobial ColonizationAntibiotic Resistant Infection
University Health Network, Toronto
Not applicableStudy completedNCT00573521
What this trial is testing

Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

Who this might be right for
Enterobacteriaceae Infections
University of Pittsburgh 450
Testing effectiveness (Phase 2)Study completedNCT01223222
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Who this might be right for
Gram-positive, Skin InfectionsMild Eczema/DermatosesAtopic Dermatitis
Lytix Biopharma AS 24
Not applicableStudy completedNCT01324726
What this trial is testing

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

Who this might be right for
Escherichia Coli InfectionsKlebsiella Pneumonia
American University of Beirut Medical Center 100
Not applicableUnknownNCT03680898
What this trial is testing

Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae
Meridian Bioscience, Inc. 1,200
Testing effectiveness (Phase 2)Study completedNCT01004445
What this trial is testing

Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Who this might be right for
Pneumonia
Bayer 69